Caenorhabditis elegans for rare disease modeling and drug discovery: strategies and strengths

Although nearly 10% of Americans suffer from a rare disease, clinical progress in individual rare diseases is severely compromised by lack of attention and research resources compared to common diseases. It is thus imperative to investigate these diseases at their most basic level to build a foundat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Peter A. Kropp (Autor), Rosemary Bauer (Autor), Isabella Zafra (Autor), Carina Graham (Autor), Andy Golden (Autor)
Format: Llibre
Publicat: The Company of Biologists, 2021-08-01T00:00:00Z.
Matèries:
Accés en línia:Connect to this object online.
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

Connect to this object online.

3rd Floor Main Library

Detall dels fons de 3rd Floor Main Library
Signatura: A1234.567
Còpia 1 Disponible